Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes
Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535)
10/2005
10/26/2005CN1224700C Post-treatment process of silkworm gene engineering phytase prepn
10/26/2005CN1224697C Process for preparation of amino alcohols and derivatives thereof
10/25/2005US6958433 Transgenic mice overexpressing aspartyl protease 2 (ASP2)
10/25/2005US6958361 Drugs, vaccines
10/25/2005US6958322 specified amino acid substitutions; more readily activated by factor XIa, high stability, and which can be activated by means of factor XIa or a derivative; pharmaceutical preparation with factor VIII inhibitory bypass activity
10/25/2005US6958318 Recombinant bacterial cells for delivery of PNP to tumor cells
10/25/2005US6958238 Isolated dishevelled associated kinases, polynucleotides encoding the kinases, and methods of use thereof
10/25/2005US6958231 Determination concentration of creatine, creatine in sample by generating hydrogen peroxide; calibrtaion
10/25/2005US6958230 Isolated from Steptomyces (Sbf-I); Polymaerase Chain Reaction (PCR).
10/25/2005US6958228 Nucleotide sequences coding enzymatic polypeptides; for use in food processing and human therapeutics
10/25/2005US6958222 Methane or methanol as sole carbon source; Embden-Meyerhof carbon pathway comprising a gene encoding a pyrophosphate dependent phosphofructokinase; biomass contains protein, carbohydrates and pigment on industrial scale
10/25/2005US6958214 Polymorphic kinase anchor proteins and nucleic acids encoding the same
10/25/2005US6958212 coupling of a pharmaceutically active compound to a polymer using a conjugate addition reaction, and the cross-linking of the polymer to form a biomaterial, in some embodiments using conjugate addition reactions; controlled release of drug
10/25/2005US6958152 Human phospholipase C delta 5
10/25/2005CA2292955C Carbohydrate-based enzyme granulates
10/25/2005CA2137548C Morphinone reductase for the preparation of hydromorphone and hydrocodone
10/25/2005CA2039165C Plants with modified flowers
10/20/2005WO2005098043A2 Ligand-dependent protein splicing
10/20/2005WO2005098038A2 Use of rna polymerase as an information-dependent molecular motor
10/20/2005WO2005098030A2 Method for the identification of fungicidally-effective compounds based on thioredoxin reductases
10/20/2005WO2005098016A2 Methods for producing hyaluronic acid
10/20/2005WO2005098001A1 Novel transformant
10/20/2005WO2005098000A1 Recombinant d-amino acid oxidase
10/20/2005WO2005097999A1 Method for improving plants
10/20/2005WO2005097990A1 Fed-batch fermentation process and culture medium for the production of plasmid dna in e.coli on a manufacturing scale
10/20/2005WO2005097986A1 Highly purified proteinase k
10/20/2005WO2005097985A1 1,3-specific lipase powder, method of producing the same and utilization of the same
10/20/2005WO2005097984A1 Lipase powder, process for producing the same and use thereof
10/20/2005WO2005097983A2 Structure of protein kinase c theta and related applications
10/20/2005WO2005097982A2 Pufa-pks genes from ulkenia
10/20/2005WO2005097824A2 Cytokinin oxidase sequences and methods of use
10/20/2005WO2005097818A2 An assay system for screening protease inhibitors
10/20/2005WO2005096804A2 Self-processing plants and plant parts
10/20/2005WO2005096781A2 Methods and compositions for treating gain-of-function disorders using rna interference
10/20/2005WO2005083431A3 Binding agents
10/20/2005WO2005078077A3 Acid alpha-glucosidase and fragments thereof
10/20/2005WO2005062867A3 Novel carotenoids ketolases
10/20/2005WO2005035760A3 Molecular nanomotor
10/20/2005WO2004113528A3 Isoforms of elf-5a: senescence-induced elf5a; wounding-induced elf-5a; growth elf-5a; and dhs
10/20/2005WO2004096157A3 Treatment of igai deposition diseases
10/20/2005WO2004094344A3 Methods for production of recombinant urokinase
10/20/2005WO2004072224A9 Detection of ochratoxin a producing fungi
10/20/2005WO2004013152A3 Novel targets for lithium therapy
10/20/2005WO2004007684A3 Synthetic tag genes
10/20/2005US20050235378 DNA encoding a plant deoxyhypusine synthase, a plant eukaryotic initiation factor 5A, transgenic plants and a method for controlling senescence programmed and cell death in plants
10/20/2005US20050235375 Transcription factors of cereals
10/20/2005US20050235370 Spatiotemporally controlled adult somatic mutagenesis system
10/20/2005US20050235367 Regulatory sequences capable of conferring expression of a heterologous DNA sequence in endothelial cells and uses thereof
10/20/2005US20050234075 Agents which regulate, inhibit, or modulate the activity and/or expression of connective tissue growth factor (ctgf) as a unique means to both lower intraocular pressure and treat glaucomatous retinopathies/optic neuropathies
10/20/2005US20050233983 Treatment of rumen acidosis with alpha-amylase inhibitors
10/20/2005US20050233965 regulating vascular permeability. A peptide inhibitor of p21-activated kinase has been found to inhibit the increase in vascular permeability induced by several factors. The present invention further provides methods of identifying regulators of vascular permeability.
10/20/2005US20050233434 Cytosolic phospholipase A2-Gamma enzymes and polynucleotides encoding same
10/20/2005US20050233433 Novel type II restriction endonuclease, CspCI, obtainable from Citrobacter species 2144 and a process for producing the same
10/20/2005US20050233432 Novel type II restriction endonuclease, BtgZI, obtainable from bacillus thermoglucosidasius 36A and a process for producing the same
10/20/2005US20050233431 Antibiotics; thioesterases; host cells
10/20/2005US20050233430 Erythrose reductase, its cDNA and cell which the cDNA express
10/20/2005US20050233429 vector and host cell comprising nucleic acid of invention; nucleic acid sequence encoding cyclcooxygenase-1 variant
10/20/2005US20050233424 Nucleotide sequences which code for the cysD, cysN, cysK, cysE and cysH genes
10/20/2005US20050233421 Fed-batch fermentation process and culture medium for the production of plasmid DNA in E. coli on a manufacturing scale
10/20/2005US20050233420 Method for producing cytosine nucleoside compounds
10/20/2005US20050233419 Cleaving chondroitin sulfate with a modified chondroitinase B having the amino acid sequence of the mature peptide; modifying with individual residues involved in substrate binding and catalysis
10/20/2005US20050233416 Mutant protein with insertion, deletion, or replacement; lysine production; gene expression
10/20/2005US20050233414 Comprises nucleotide sequences coding protein which are involved in the biosynthesis of oligosaccharide antibiotics and bactericides; bioreactors for human medicines
10/20/2005US20050233412 An artificial mutant tRNA synthetase; aminoacylates an orthogonal tRNA with beta -GlcNAc-serine
10/20/2005US20050233411 Compositions and methods for cleaving IAP
10/20/2005US20050233402 Heparinase III HLGAG fragments and uses thereof
10/20/2005US20050233389 Methods and compositions for peptide and protein labeling
10/20/2005US20050233375 13245, a novel human myotonic dystrophy type protein kinase and uses therefor
10/20/2005US20050233373 Nucleotide sequence which code for the metH gene
10/20/2005US20050233369 Biosynthetic gene cluster for jerangolids
10/20/2005US20050233368 Canine pancreatic lipase
10/20/2005US20050233355 Human cDNAs encoding polypeptides having kinase functions
10/20/2005US20050233349 Crystal structure of ribosomal protein L11/GTPase activating region rRNA and uses thereof
10/20/2005US20050233348 Using recombinant protein binding domains as tools for monitoring ligand binding activity in cells
10/20/2005US20050233347 Can be used for the treatment of diabetes or for delaying the onset of diabetes
10/20/2005US20050233328 Methods of identifying compounds that modulate protein activity
10/20/2005US20050233315 Cloned genes encoding reverse transcriptase lacking RNase H activity
10/20/2005US20050233312 collecting a sample from an HIV-infected patient and extracting nucleic acid to determine if corresponding amino acid sequence comprises mutation selected from R41S, R41T, R41G and K70E in the protease region to determine a change in susceptibility of patient HIV strain to protease inhibitor
10/20/2005US20050233308 Method for modifying a property of a protein
10/20/2005US20050232934 Recombinant reverse transcriptases
10/20/2005US20050232932 Compositions and methods for dendritic cell-based immunotherapy
10/20/2005US20050232914 Highly purified mocarhagin, a cobra venom protease, polynucleotides encoding same and related proteases, and therapeutic uses thereof
10/20/2005US20050232912 Enzyme phosphorylating ser46 of p53
10/20/2005US20050230206 Wave energy converter (WEC) with magnetic braking
10/20/2005CA2563427A1 Pufa-pks genes from ulkenia
10/20/2005CA2563173A1 Methods for producing hyaluronic acid in a bacillus cell
10/20/2005CA2561232A1 Structure of protein kinase c theta c
10/20/2005CA2560655A1 Method for improving plants
10/20/2005CA2558603A1 Self-processing plants and plant parts
10/20/2005CA2530200A1 1,3-specific lipase powder, methods for producing the same and use thereof
10/20/2005CA2529985A1 A lipase powder, methods for producing the same and use thereof
10/19/2005EP1586649A2 Mutant proteins having lower allergenic response in humans and methods for constructing, identifying and producing such proteins
10/19/2005EP1586648A1 Juvenile hormone transmethylase genes and method of using the same
10/19/2005EP1586647A1 Process for the biological production of 1,3-propanediol with high titer
10/19/2005EP1586642A2 Tumor supressor genes, proteins encoded thereby and use of said genes and proteins
10/19/2005EP1586637A1 Novel nitrile hydratase
10/19/2005EP1586636A1 Hydantoinase variants with improved properties and their use for the production of amino acids
10/19/2005EP1586635A1 Fusion proteins with parts of immunoglobulins, their production and use
10/19/2005EP1586329A1 Botulinum toxin pharmaceutical compositions
10/19/2005EP1586241A1 Improved coating for stabilizing active ingredients
1 ... 601 602 603 604 605 606 607 608 609 610 611 612 613 614 615 616 617 618 619 620 621 ... 1416